Waterhouse RN - Search Results

1

Imaging sigma receptors: applications in drug development.

Collier TL, Waterhouse RN, Kassiou M. Collier TL, et al. Among authors: waterhouse rn. Curr Pharm Des. 2007;13(1):51-72. doi: 10.2174/138161207779313740. Curr Pharm Des. 2007. PMID: 17266588 Review.

2

In vitro and in vivo binding of neuroactive steroids to the sigma-1 receptor as measured with the positron emission tomography radioligand [18F]FPS.

Waterhouse RN, Chang RC, Atuehene N, Collier TL. Waterhouse RN, et al. Synapse. 2007 Jul;61(7):540-6. doi: 10.1002/syn.20369. Synapse. 2007. PMID: 17447254

3

Assessment of cancer-associated biomarkers by positron emission tomography: advances and challenges.

Collier TL, Lecomte R, McCarthy TJ, Meikle S, Ruth TJ, Scopinaro F, Signore A, VanBrocklin H, van De Wiele C, Waterhouse RN. Collier TL, et al. Among authors: waterhouse rn. Dis Markers. 2002;18(5-6):211-47. doi: 10.1155/2002/879647. Dis Markers. 2002. PMID: 14646039 Free PMC article. Review.

4

Re symposium: "Approaches to optimize the discovery of CNS receptor imaging probes for use in drug discovery and development".

Waterhouse RN, McCarthy TJ, Collier TL, Burns HD. Waterhouse RN, et al. Mol Imaging Biol. 2003 Nov-Dec;5(6):347-9. doi: 10.1016/j.mibio.2003.10.002. Mol Imaging Biol. 2003. PMID: 14667489 No abstract available.

5

Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for sigma-1 receptors: in vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]pip eri dine.

Waterhouse RN, Mardon K, Giles KM, Collier TL, O'Brien JC. Waterhouse RN, et al. J Med Chem. 1997 May 23;40(11):1657-67. doi: 10.1021/jm960720+. J Med Chem. 1997. PMID: 9171875

6

Examination of four 123I-labeled piperidine-based sigma receptor ligands as potential melanoma imaging agents: initial studies in mouse tumor models.

Waterhouse RN, Chapman J, Izard B, Donald A, Belbin K, O'Brien JC, Collier TL. Waterhouse RN, et al. Nucl Med Biol. 1997 Aug;24(6):587-93. doi: 10.1016/s0969-8051(97)00030-9. Nucl Med Biol. 1997. PMID: 9316089

7

In vivo evaluation of [18F]1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine: a selective sigma-1 receptor radioligand for PET.

Waterhouse RN, Collier TL. Waterhouse RN, et al. Nucl Med Biol. 1997 Feb;24(2):127-34. doi: 10.1016/s0969-8051(96)00184-9. Nucl Med Biol. 1997. PMID: 9089705

8

Brain Penetration of the ROS1/ALK Inhibitor Lorlatinib Confirmed by PET.

Collier TL, Maresca KP, Normandin MD, Richardson P, McCarthy TJ, Liang SH, Waterhouse RN, Vasdev N. Collier TL, et al. Among authors: waterhouse rn. Mol Imaging. 2017 Jan-Dec;16:1536012117736669. doi: 10.1177/1536012117736669. Mol Imaging. 2017. PMID: 29067878 Free PMC article.

9

Synthesis and preliminary PET imaging of ¹¹C and ¹⁸F isotopologues of the ROS1/ALK inhibitor lorlatinib.

Collier TL, Normandin MD, Stephenson NA, Livni E, Liang SH, Wooten DW, Esfahani SA, Stabin MG, Mahmood U, Chen J, Wang W, Maresca K, Waterhouse RN, El Fakhri G, Richardson P, Vasdev N. Collier TL, et al. Among authors: waterhouse rn. Nat Commun. 2017 Jun 8;8:15761. doi: 10.1038/ncomms15761. Nat Commun. 2017. PMID: 28594000 Free PMC article.

10

Radiosynthesis and in vivo evaluation of the pseudopeptide delta-opioid antagonist [(125)I]ITIPP(psi).

Collier TL, Schiller PW, Waterhouse RN. Collier TL, et al. Among authors: waterhouse rn. Nucl Med Biol. 2001 May;28(4):375-81. doi: 10.1016/s0969-8051(01)00193-7. Nucl Med Biol. 2001. PMID: 11395309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page